Hundreds of Cialis and Viagra Melanoma Lawsuits Filed

In April of 2016, the Judicial Panel on Multidistrict Litigation determined that coordination of federal court lawsuits involving men who developed melanoma after taking Viagra was appropriate. MDL No. 2691, styled In Re:  Viagra (Sildenafil Citrate) Products Liability Litigation Viagra, was then established before Judge Seeborg, a federal court judge, in the Northern District of … Continued

Potential Eliquis MDL Discussed at JPML Hearing in Miami Beach

Miami Beach was the place to be for mass tort lawyers last week, with two drug and medical device conferences as well as a critical hearing before the Judicial Panel on Multidistrict Litigation (also known as the “JPML”). The Judicial Panel, a group of federal judges that meets every two months to consider requests to … Continued

Bacteria Found in Cardiac Patients Linked to Heater-Cooler Machine

Heater-Cooler Machine Spreads Germs in Sterile Areas The medical device sounds well-intended enough: a heater-cooler machine used during heart surgery to control a patient’s body temperature. Doctors employ them in the hundreds of thousands of cardiac procedures they conduct every year in hospitals across the country. Turns out, the LivaNova PLC (formerly Sorin Group Deutschland GmbH) … Continued

Essure Birth Control Urged To Warn Women About Product Risks

The U.S. Food and Drug Administration is concerned that women are not as knowledgeable as they should be about the risks associated with permanent Essure birth control. The agency now recommends a black-box warning for the product along with a new patient checklist. The New FDA Guidance on Essure Birth Control The new guidance addresses hysteroscopically placed … Continued

Updates from JPML – Roundup, Taxotere, Abilify

The Judicial Panel on Multidistrict Litigation met in late September to discuss the establishment of multidistrict litigation proceedings for several new mass tort cases, including Abilify compulsive gambling claims, talcum powder ovarian cancer lawsuits, Taxotere permanent hair loss actions, and Roundup-related cancer cases. At the time that the request for coordination was made, 37 different … Continued

Newly Filed Xarelto Cases and Litigation Updates

Searcy Denney has continued its commitment to seeking justice on behalf of victims of Xarelto (rivaroxaban) with the filing of a number of additional individual lawsuits on behalf of injured patients over the past few weeks. All of these personal injury and wrongful death cases will become part of MDL No. 2592, the national, coordinated … Continued

Doctors to Patients: “Take A Hike”

The National Park Service is celebrating its centennial – an historic occasion that will culminate Aug. 25. On that date in 1916, President Woodrow Wilson signed into law an act creating a new bureau within the Department of the Interior that would bear responsibility for protecting the then-35 parks in existence. Today, more than 400 … Continued

Is Sponsor-Submitted Clinical Data Safe?

Is Sponsor-Submitted Clinical Data Safe? The U.S. Food and Drug Administration has a tricky task at hand when it comes to reviewing, evaluating, investigating and eventually approving prescription medications. Yes, the agency has a mission to ensure patient safety, and yes, a formal process must be followed before a medication can be marketed, but no, … Continued

Questions About FDA’s Drug Approval Process Answered

The road to U.S. Food and Drug Administration approval of pharmaceutical manufacturers’ medications is a long and winding one. A dynamic process tinged with favorable – and unfavorable – factors can take a drug from lab to label in 10 months or less. Consumer clarity on how certain products make it to market and whether … Continued

Recognized by